Harald Lux1,2, Xaver Baur3,4, Lygia Therese Budnik5, Astrid Heutelbeck6, João Paulo Teixeira7,8, Emeri Neumann9, Diana Adliene10, Judita Puišo10, David Lucas11, Jakob Löndahl12, Athanasios Damialis13, Ozlem Goksel14, Hans Orru9,15. 1. Occupational, Social and Environmental Medicine, University Hospital Jena - Friedrich Schiller University Jena, Erlanger Allee 103, 07747, Jena, Germany. harald.lux@med.uni-jena.de. 2. Department of Psychiatry and Psychotherapy, Ruppiner Kliniken, Neuruppin, Germany. harald.lux@med.uni-jena.de. 3. European Society for Environmental and Occupational Medicine, Berlin, Germany. 4. Emeritus University of Hamburg, Hamburg, Germany. 5. Translational Toxicology and Immunology Unit, Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 6. Occupational, Social and Environmental Medicine, University Hospital Jena - Friedrich Schiller University Jena, Erlanger Allee 103, 07747, Jena, Germany. 7. Environmental Health Department, National Institute of Health, Porto, Portugal. 8. EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal. 9. Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia. 10. Department of Physics, Kaunas University of Technology, Kaunas, Lithuania. 11. EA4324 ORPHY Laboratory, Occidental Brittany University Brest, Brest, France. 12. Ergonomics and Aerosol Technology, Lund University, Lund, Sweden. 13. Chair and Institute of Environmental Medicine, UNIKA-T, Technical University of Munich and Helmholtz Centre Munich, Augsburg, Germany. 14. Laboratory of Occupational & Environmental Respiratory Diseases, Division of Immunology, Allergy and Asthma, Department of Pulmonary Medicine, Faculty of Medicine, EGE University, Izmir, Turkey. 15. Section of Sustainable Health, Umea University, Umea, Sweden.
Abstract
BACKGROUND: Until today, industrial sources contribute to the multifaceted contamination of environmental air. Exposure to air pollutants has the potential to initiate and promote asthma and chronic obstructive pulmonary disease (COPD). At global scale, both entities cause the majority of about 4 million annual deaths by respiratory disease. However, we identified industrial contamination as a subgroup of air pollution that may be associated with this burden and is underinvestigated in research. Therefore, the aim of this study is to investigate associations between substances industrially released into environmental air and the occurrence of asthma and COPD in the human population. Here we present the protocol for our systematic review of the current evidence. METHODS: The following determinations will be applied during the systematic review process and are specified in the protocol that complies with the PRISMA-P statement. Populations of children and adults, as well as outdoor workers, exposed to industrially released air pollutants are of interest. Eligible studies may include subjects as controls who are non- or less exposed to the investigated air pollutants. The outcomes new-onset asthma and/or COPD investigated with risk ratio, odds ratio, hazard ratio, incidence rate ratio, cumulative incidence, and incidence rate are eligible. We will search the electronic literature databases EMBASE, MEDLINE, and Web of Science for peer-reviewed reports of incidence studies and incidence case-control studies. After systematic sorting of initial records, included studies will be subjected to quality assessment. Data will be synthesized qualitatively and, if appropriate, quantitatively for risk ratio and odds ratio. We will maintain and provide a PRISMA report. DISCUSSION: Results of this systematic review may indicate alterations of incidence and risk of asthma and/or COPD in populations within industrial exposure radiuses including outdoor workplaces. Specific causal substances and compositions will be identified, but results will depend on the exposure assessment of the eligible studies. Our approach covers effects of industrial contributions to overall air pollution if studies reportedly attribute investigated emissions to industry. Results of this study may raise the question wether the available higher-level evidence sufficiently covers the current scale of industrial exposure scenarios and their potential harm to respiratory health. TRIAL REGISTRATION: This protocol was registered in PROSPERO, registration number CRD42020151573 .
BACKGROUND: Until today, industrial sources contribute to the multifaceted contamination of environmental air. Exposure to air pollutants has the potential to initiate and promote asthma and chronic obstructive pulmonary disease (COPD). At global scale, both entities cause the majority of about 4 million annual deaths by respiratory disease. However, we identified industrial contamination as a subgroup of air pollution that may be associated with this burden and is underinvestigated in research. Therefore, the aim of this study is to investigate associations between substances industrially released into environmental air and the occurrence of asthma and COPD in the human population. Here we present the protocol for our systematic review of the current evidence. METHODS: The following determinations will be applied during the systematic review process and are specified in the protocol that complies with the PRISMA-P statement. Populations of children and adults, as well as outdoor workers, exposed to industrially released air pollutants are of interest. Eligible studies may include subjects as controls who are non- or less exposed to the investigated air pollutants. The outcomes new-onset asthma and/or COPD investigated with risk ratio, odds ratio, hazard ratio, incidence rate ratio, cumulative incidence, and incidence rate are eligible. We will search the electronic literature databases EMBASE, MEDLINE, and Web of Science for peer-reviewed reports of incidence studies and incidence case-control studies. After systematic sorting of initial records, included studies will be subjected to quality assessment. Data will be synthesized qualitatively and, if appropriate, quantitatively for risk ratio and odds ratio. We will maintain and provide a PRISMA report. DISCUSSION: Results of this systematic review may indicate alterations of incidence and risk of asthma and/or COPD in populations within industrial exposure radiuses including outdoor workplaces. Specific causal substances and compositions will be identified, but results will depend on the exposure assessment of the eligible studies. Our approach covers effects of industrial contributions to overall air pollution if studies reportedly attribute investigated emissions to industry. Results of this study may raise the question wether the available higher-level evidence sufficiently covers the current scale of industrial exposure scenarios and their potential harm to respiratory health. TRIAL REGISTRATION: This protocol was registered in PROSPERO, registration number CRD42020151573 .
Entities:
Keywords:
Air pollution; Chronic obstructive pulmonary disease; Inhaled particles; Occupational exposure; Outdoor exposure; Respiratory disease; Systematic literature review
Authors: R A Bontsevich; A V Adonina; Y R Vovk; G A Batisheva; O V Cherenkova; G G Ketova; V O Barysheva; E V Luchinina; T G Pokrovskaia Journal: Arch Razi Inst Date: 2022-02-28
Authors: Seo Yun Hwang; Seogsong Jeong; Seulggie Choi; Dong Hyun Kim; Seong Rae Kim; Gyeongsil Lee; Joung Sik Son; Sang Min Park Journal: Int J Environ Res Public Health Date: 2021-04-04 Impact factor: 3.390